Japan, Jan. 20 -- DAINIPPON SUMITOMO PHARMA CO LTD has got intellectual property rights for '2-HETEROARYLAMINOQUINAZOLINONE DERIVATIVE.' Other related details are as follows:
Application Number: JP,2021-203486
Category (FI): A61K31/517,A61K31/519,A61P25/08,A61P25/14,A61P25/18,A61P25/22,A61P25/24,A61P25/28,C07D401/12,C07D401/14,C07D403/12,C07D405/14,C07D407/14,C07D409/12,C07D409/14,C07D413/12,C07D413/14,C07D417/12,C07D417/14,C07D451/00,C07D451/04,C07D453/00,C07D471/04,101,C07D471/04,106,C07D471/04,106@A,C07D471/04,106@Z,C07D471/04,107@E,C07D471/04,108@A,C07D471/04,116,C07D471/04,117@N
Stage: Grant (IP right granted following substantive examination.)
Filing Date: Dec. 15, 2021
Publication Date: March 8, 2022
The original document can b...